Nuclear-Based Labeling of Cellular Immunotherapies: A Simple Protocol for Preclinical Use
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Nuclear-Based Labeling of Cellular Immunotherapies: A Simple Protocol for Preclinical Use ; volume:26 ; number:4 ; day:3 ; month:7 ; year:2024 ; pages:555-568 ; date:8.2024
Molecular imaging & biology ; 26, Heft 4 (3.7.2024), 555-568, 8.2024
- Creator
-
Volpe, Alessia
Lyashchenko, Serge K.
Ponomarev, Vladimir
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s11307-024-01923-z
- URN
-
urn:nbn:de:101:1-2410112122312.161174211525
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:33 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Volpe, Alessia
- Lyashchenko, Serge K.
- Ponomarev, Vladimir
- SpringerLink (Online service)
Other Objects (12)
Molecular imaging of cellular immunotherapies in experimental and therapeutic settings
Modeling human tumor-immune environments in vivo for the preclinical assessment of immunotherapies
Cellular Immunotherapies for Multiple Myeloma: Current Status, Challenges, and Future Directions
Cellular therapeutics and immunotherapies in wound healing – on the pulse of time?
Immunotherapies in solid tumors
Immunotherapies in rare cancers
Synthesis and Cellular Labeling of Caged Phosphatidylinositol Derivatives
Novel cellular immunotherapies for hematological malignancies: recent updates from the 2021 ASH annual meeting
Application of blood brain barrier models in pre-clinical assessment of glioblastoma-targeting CAR-T based immunotherapies
Neurotoxicity of novel cancer immunotherapies
Emerging Immunotherapies for Parkinson Disease
Advances in Prostate Cancer Immunotherapies
Molecular imaging of cellular immunotherapies in experimental and therapeutic settings
Modeling human tumor-immune environments in vivo for the preclinical assessment of immunotherapies
Cellular Immunotherapies for Multiple Myeloma: Current Status, Challenges, and Future Directions
Cellular therapeutics and immunotherapies in wound healing – on the pulse of time?
Immunotherapies in solid tumors
Immunotherapies in rare cancers
Synthesis and Cellular Labeling of Caged Phosphatidylinositol Derivatives
Novel cellular immunotherapies for hematological malignancies: recent updates from the 2021 ASH annual meeting
Application of blood brain barrier models in pre-clinical assessment of glioblastoma-targeting CAR-T based immunotherapies
Neurotoxicity of novel cancer immunotherapies
Emerging Immunotherapies for Parkinson Disease
Advances in Prostate Cancer Immunotherapies
Molecular imaging of cellular immunotherapies in experimental and therapeutic settings
Modeling human tumor-immune environments in vivo for the preclinical assessment of immunotherapies
Cellular Immunotherapies for Multiple Myeloma: Current Status, Challenges, and Future Directions
Cellular therapeutics and immunotherapies in wound healing – on the pulse of time?
Immunotherapies in solid tumors
Immunotherapies in rare cancers
Synthesis and Cellular Labeling of Caged Phosphatidylinositol Derivatives
Novel cellular immunotherapies for hematological malignancies: recent updates from the 2021 ASH annual meeting
Application of blood brain barrier models in pre-clinical assessment of glioblastoma-targeting CAR-T based immunotherapies
Neurotoxicity of novel cancer immunotherapies
Emerging Immunotherapies for Parkinson Disease